Intro Widget

Heart is an international peer reviewed journal that keeps cardiologists up to date with important research advances in cardiovascular disease. New scientific developments are highlighted in editorials and put in context with concise review articles. There is one free Editor’s Choice article in each issue, with open access options available to authors for all articles. Education in Heart articles provide a comprehensive, continuously updated, cardiology curriculum.

Heart promotes active interchange among researchers and readers to come together as a community to advance science and improve patient care via regular free audio podcasts, letters to the Editor, a blog summarising the latest cardiology research, and news via Twitter and Facebook.

Heart is an official journal of the British Cardiovascular Society.

Editor-in-Chief: Professor Catherine Otto, University of Washington, USA
Editorial team

NEW: BMJ Cardiology website showcasing the latest cardiology content from across BMJ

Impact Factor


Heart considers unsolicited submissions of a variety of article types, including original research, systematic reviews, meta-analyses, and image challenge questions. Review articles are usually commissioned but unsolicited reviews may be considered for topics of interest to the journal's readers.
Information is also provided on editorial policies and open access.

All manuscripts should be submitted online.

Impact Factor


Blog Posts

Featured Video

Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia

To cite: MundalLJ, IglandJ, VeierødMB, et al. Heart. Published Online First: 05 April 2018. doi: 10.1136/heartjnl-2017-312706
Read the full article here: linkObjective: The primary objective was to study the risk of acute myocardial infarction (AMI) and coronary heart disease (CHD) in patients with familial hypercholesterolaemia (FH) and compare with the risk in the general population.
Conclusion: Patients with FH are at severely increased risk of AMI and CHD compared with the general population. The highest excess risk was in the youngest group aged 25–39 years, in both sexes.

Related Content